Case number IPR2025-01269
Fresenius Kabi SwissBiosim, GmbH et al. v. Regeneron Pharmaceuticals, Inc. > Documents
| Date Field | Doc. No. | Party | Description |
|---|---|---|---|
| Jul 14, 2025 | 1 | petitioner | Petitioner Fresenius Kabi SwissBiosim, GmBh Power of Attorney Download |
| Jul 14, 2025 | 2 | petitioner | Fresenius Kabi SwissBiosim, GmBH Petition for IPR of USP10,828,345 Download |
| Jul 23, 2025 | 3 | board | Notice: Notice filing date accorded Download |
| Aug 4, 2025 | 4 | patent_owner | Notice: Power of Attorney Download |
| Aug 4, 2025 | 5 | patent_owner | Notice: Mandatory Notice Download |
| Sep 23, 2025 | 6 | patent_owner | Patent Owner's Discretionary Denial Brief Download |
| Oct 23, 2025 | 7 | petitioner | Petitioner's Opposition to Patent Owner's Request for Discretionary Denial Download |
| Oct 24, 2025 | 8 | patent_owner | Regeneron's Preliminary Patent Owner Response (IPR2025-01269) Download |
| Nov 3, 2025 | 9 | patent_owner | Patent Owner's Reply in Support of Discretionary Denial Download |
| Nov 5, 2025 | 10 | petitioner | Petitioner's Sur-Reply in Opposition to Patent Owner's Request for Discretionary Denial Download |
| Nov 20, 2025 | 11 | board | Director Discretionary Decision: Refer Download |
| Jul 14, 2025 | 1001 | petitioner | Ex. 1001 Download |
| Jul 14, 2025 | 1002 | petitioner | Ex. 1002 Download |
| Jul 14, 2025 | 1003 | petitioner | Ex. 1003 Download |
| Jul 14, 2025 | 1004 | petitioner | Ex. 1004 Download |
| Jul 14, 2025 | 1005 | petitioner | Ex. 1005 Download |
| Jul 14, 2025 | 1006 | petitioner | Ex. 1006 Download |
| Jul 14, 2025 | 1007 | petitioner | Ex. 1007 Download |
| Jul 14, 2025 | 1008 | petitioner | Ex. 1008 Download |
| Jul 14, 2025 | 1009 | petitioner | Ex. 1009 Download |
| Jul 14, 2025 | 1010 | petitioner | Ex. 1010 Download |
| Jul 14, 2025 | 1011 | petitioner | Ex. 1011 Download |
| Jul 14, 2025 | 1012 | petitioner | Ex. 1012 Download |
| Jul 14, 2025 | 1013 | petitioner | Ex. 1013 Download |
| Jul 14, 2025 | 1014 | petitioner | Ex. 1014 Download |
| Jul 14, 2025 | 1015 | petitioner | Ex. 1015 Download |
| Jul 14, 2025 | 1016 | petitioner | Ex. 1016 Download |
| Jul 14, 2025 | 1017 | petitioner | Ex. 1017 Download |
| Jul 14, 2025 | 1018 | petitioner | Ex. 1018 Download |
| Jul 14, 2025 | 1019 | petitioner | Ex. 1019 Download |
| Jul 14, 2025 | 1020 | petitioner | Ex. 1020 Download |
| Jul 14, 2025 | 1021 | petitioner | Ex. 1021 Download |
| Jul 14, 2025 | 1022 | petitioner | Ex. 1022 Download |
| Jul 14, 2025 | 1023 | petitioner | Ex. 1023 Download |
| Jul 14, 2025 | 1024 | petitioner | Ex. 1024 Download |
| Jul 14, 2025 | 1025 | petitioner | Ex. 1025 Download |
| Jul 14, 2025 | 1026 | petitioner | Ex. 1026 Download |
| Jul 14, 2025 | 1027 | petitioner | Ex. 1027 Download |
| Jul 14, 2025 | 1028 | petitioner | Ex. 1028 Download |
| Jul 14, 2025 | 1029 | petitioner | Ex. 1029 Download |
| Jul 14, 2025 | 1031 | petitioner | Ex. 1031 Download |
| Jul 14, 2025 | 1032 | petitioner | Ex. 1032 Download |
| Jul 14, 2025 | 1033 | petitioner | Ex. 1033 Download |
| Jul 14, 2025 | 1034 | petitioner | Ex. 1034 Download |
| Jul 14, 2025 | 1035 | petitioner | Ex. 1035 Download |
| Jul 14, 2025 | 1036 | petitioner | Ex. 1036 Download |
| Jul 14, 2025 | 1037 | petitioner | Ex. 1037 Download |
| Jul 14, 2025 | 1038 | petitioner | Ex. 1038 Download |
| Jul 14, 2025 | 1039 | petitioner | Ex. 1039 Download |
| Jul 14, 2025 | 1040 | petitioner | Ex. 1040 Download |
| Jul 14, 2025 | 1041 | petitioner | Ex. 1041 Download |
| Jul 14, 2025 | 1042 | petitioner | Ex. 1042 Download |
| Jul 14, 2025 | 1043 | petitioner | Ex. 1043 Download |
| Jul 14, 2025 | 1044 | petitioner | Ex. 1044 Download |
| Jul 14, 2025 | 1045 | petitioner | Ex. 1045 Download |
| Jul 14, 2025 | 1046 | petitioner | Ex. 1046 Download |
| Jul 14, 2025 | 1047 | petitioner | Ex. 1047 Download |
| Jul 14, 2025 | 1048 | petitioner | Ex. 1048 Download |
| Jul 14, 2025 | 1049 | petitioner | Ex. 1049 Download |
| Jul 14, 2025 | 1050 | petitioner | Ex. 1050 Download |
| Jul 14, 2025 | 1051 | petitioner | Ex. 1051_Part 1 Download |
| Jul 14, 2025 | 1051 | petitioner | Ex. 1051_Part 2 Download |
| Jul 14, 2025 | 1052 | petitioner | Ex. 1052 Download |
| Jul 14, 2025 | 1053 | petitioner | Ex. 1053 Download |
| Jul 14, 2025 | 1054 | petitioner | Ex. 1054 Download |
| Jul 14, 2025 | 1055 | petitioner | Ex. 1055 Download |
| Oct 23, 2025 | 1056 | petitioner | Ex. 1056 Download |
| Oct 23, 2025 | 1057 | petitioner | Ex. 1057 Download |
| Sep 23, 2025 | 2001 | patent_owner | EX2001 - 16159282 File Certified - Part 6 of 6 Download |
| Sep 23, 2025 | 2001 | patent_owner | EX2001 - 16159282 File Certified - Part 4 of 6 Download |
| Sep 23, 2025 | 2001 | patent_owner | EX2001 - 16159282 File Certified - Part 3 of 6 Download |
| Sep 23, 2025 | 2001 | patent_owner | EX2001 - 16159282 File Certified - Part 5 of 6 Download |
| Sep 23, 2025 | 2001 | patent_owner | EX2001 - 16159282 File Certified - Part 1 of 6 Download |
| Sep 23, 2025 | 2001 | patent_owner | EX2001 - 16159282 File Certified - Part 2 of 6 Download |
| Sep 23, 2025 | 2002 | patent_owner | EX2002 - Compare Record History ver 9-10 2009-04-28 NCT00509795 Download |
| Sep 23, 2025 | 2003 | patent_owner | EX2003 - NCT-795 as submitted in App. No. 14-972,560 Download |
| Sep 23, 2025 | 2004 | patent_owner | EX2004 - Donald Trump Remarks Transcript October 7th Download |
| Sep 23, 2025 | 2005 | patent_owner | EX2005 - Regeneron - the Company that Trump claims cured his Covid Download |
| Sep 23, 2025 | 2006 | patent_owner | EX2006 - Trump calls coronavirus treatment he received a cure Download |
| Oct 24, 2025 | 2007 | patent_owner | U.S. Provisional Application No. 61/432,245 Download |
| Oct 24, 2025 | 2008 | patent_owner | U.S. Provisional Application No. 61/434,836 Download |
| Oct 24, 2025 | 2009 | patent_owner | U.S. Provisional Application No. 61/561,957 Download |
| Oct 24, 2025 | 2010 | patent_owner | Eylea Label (November 18, 2011) Download |
| Oct 24, 2025 | 2011 | patent_owner | P.J. Rosenfeld et al., Ranibizumab for Neovascular Age Related Macular Degeneration, 355 N. ENG. J. MED. 1419 (2006) Download |
| Oct 24, 2025 | 2012 | patent_owner | C.D. Regillo et al., Randomized, Double-Masked, ShamControlled Clinical Trial of Ranibizumab for Neovascular Age-Related Macular Degeneration: PIER Study Year 1, 145 AM. J. OPHTHALMOLOGY 145(2): 239-248 (2008) Download |
| Oct 24, 2025 | 2013 | patent_owner | N. M. Bressler, Antiangiogenic Approaches to Age-Related Macular Degeneration Today, 116 AM. ACAD. OPHTHALMOLOGY S15 (2009) Download |
| Oct 24, 2025 | 2014 | patent_owner | Curriculum Vitae of Dr. Neil M. Bressler, M.D. Download |
| Oct 24, 2025 | 2015 | patent_owner | Expert Declaration of Dr. Neil M. Bressler in Support of Patent Owner Preliminary Response. Download |
| Oct 24, 2025 | 2016 | patent_owner | Download |
| Oct 24, 2025 | 2017 | patent_owner | SUSTAIN - Study of Ranibizumab in Patients with Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (Dec. 09, 2010), https://www.clinicaltrials.gov/study/ NCT00331864?tab=history&a=10#version-content-panel Download |
| Oct 24, 2025 | 2018 | patent_owner | A.P. Adamis, Angiogenesis and Ophthalmic Disease, 3 ANGIOGENESIS 9 (1999) Download |
| Oct 24, 2025 | 2019 | patent_owner | G.L. Skuta et al, Retina And Vitreous 72-73, 109-114, 121, 128-29 (Section 12, 2009) Download |
| Oct 24, 2025 | 2020 | patent_owner | Barbazetto et al., Dosing Regimen and the Frequency of Macular Hemorrhages in Neovascular Age-Related Macular Degeneration Treated with Ranibizumab, 30 RETINA 1376 (2010). Download |
| Oct 24, 2025 | 2021 | patent_owner | Download |
| Oct 24, 2025 | 2022 | patent_owner | Prospective OCT Study with Lucentis for Neovascular AMD (PrONTO study), NCT00344227, ClinicalTrials.gov (June 23, 2006), https://clinicaltrials.gov/study/ NCT00344227?tab=history&a=1#version-content-panel Download |
| Oct 30, 2025 | 3101 | board | Email Correspondence Download |
